The Role of Enzalutamide in HR+ Advanced Breast Cancer

Video

Denise Yardley, MD, Senior Investigator, Sarah Cannon Research Institute, discusses the role of enzalutamide in hormone-receptor positive (HR+) advanced breast cancer.

Newsletter

Stay up to date on practice-changing data in community practice.

Recent Videos
Related Content